Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hector Sarmiento

Dentist, Periodontics New York, NY Doctor of Dentistry

NPI 1952634784 CMS profile 1274786

225 E 64Th St, Suite 1, New York, NY 10065

Open in the dashboard

General payments

$129,707

160 records reported · program years 2019–2025

Research payments

$177,676

Paid to them · 14 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hector Sarmiento of New York, NY is reported in the CMS Open Payments database as having received $129,707 across 160 general payments and $177,676 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,243 10
2024 General $143 2
2023 General $15,542 36
2023 Research $35,000 1
2022 General $21,699 23
2022 Research $35,000 1
2021 General $24,244 30
2021 Research $35,000 1
2020 General $1,672 5
2020 Research $35,386 2
2019 General $60,163 54
2019 Research $37,292 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hector Sarmiento
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Hector Sarmiento were reported at $6,243. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Hector Sarmiento Dentist, Periodontics median Middle half National median
2019 $60,163 $129 $42–$367 $163
2020 $1,672 $90 $35–$265 $114
2021 $24,244 $125 $42–$411 $132
2022 $21,699 $123 $43–$364 $149
2023 $15,542 $125 $45–$358 $160
2024 $143 $119 $42–$350 $164
2025 $6,243 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. J. Morita USA, Inc. $75,043 81 payments
  2. Geistlich Pharma, North America, Inc. $47,756 35 payments
  3. DENTSPLY IH Inc. $2,240 5 payments
  4. Thommen Medical USA, LLC $1,709 7 payments
  5. Sirona Dental Systems Inc. $1,500 2 payments
  6. Dentsply Sirona Inc $877 20 payments
  7. Salvin Dental Specialties, Inc. $341 4 payments
  8. Southern Implants North America Inc $140 2 payments
  9. Philips Electronics North America Corporation $36 1 payment
  10. Pacira Pharmaceuticals Incorporated $30 1 payment
  11. Other $37 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $60,000 12 payments
  2. Consulting Fee $35,323 7 payments
  3. Travel and Lodging $22,764 77 payments
  4. Food and Beverage $5,572 56 payments
  5. Honoraria $5,000 2 payments
  6. Education $900 1 payment
  7. Gift $148 5 payments
Products named General payments · program years 2019–2025
  1. Bio-Oss $19,291 8 payments
  2. Bio-Gide $18,836 5 payments
  3. Fibro-Gide $7,479 4 payments
  4. Implant Dentistry $2,971 22 payments
  5. Bio-Materials $2,111 17 payments
  6. CEREC $1,500 2 payments
  7. ORTHOPHOS $1,500 2 payments
  8. Inverta $140 2 payments
  9. Provata $140 2 payments
  10. WaveOne Gold Conform Fit $113 1 payment
  11. Other $174 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. J. Morita USA, Inc. $177,676 14 payments

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

480

Median for Dentist: 47

Drug cost

$4,571

Median for Dentist: $159

Branded share of claims

9.8%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cevimeline Hcl Generic 12 $1,619
Triamcinolone Acetonide Generic 34 $926
Amoxicillin Generic 181 $692
Ibuprofen Generic 135 $540
Chlorhexidine Gluconate Generic 30 $225
Azithromycin Generic 29 $207
Clarithromycin Generic 12 $114
Sodium Fluoride 5000 Plus Fluoride (Sodium) Brand 18 $110
Denta 5000 Plus Fluoride (Sodium) Brand 15 $100
Acetaminophen-Codeine Acetaminophen With Codeine Brand 14 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $30
$30 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record